SYNERMORE
Synermore is a Taiwan based biotech company focused on the research and development of innovative and biosimilar monoclonal antibodies in the areas of oncology, infectious diseases, and immune disorders. The core competence is to bring products from research stage through IND-enabling nonclinical and CMC activities to clinical stage of development.
SYNERMORE
Industry:
Biotechnology
Founded:
2013-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.synermore.com
Total Employee:
11+
Status:
Active
Contact:
+886 2 2659 0988
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Euro Google Maps Mobile Non Scaleable Content Pound Sterling Google Custom Search
Similar Organizations
Peptron
Peptron is a biotech company.
Stamperwo
Stamperwo is a biztech company.
ZIS Food Science
ZIS Food Science is a biotech company.
Investors List
Sinovac Biotech
Sinovac Biotech investment in Corporate Round - Synermore
More informations about "Synermore"
Synermore
公司目前上市产品为I类创新药泽美洛韦玛佐瑞韦单抗注射液克瑞毕，该产品为国内首个符合世界卫生组织（WHO）推荐的抗狂犬病鸡尾酒抗体。 公司目前在研产品共6个，其中生物创新药3 …See details»
Synermore Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Synermore. Use the PitchBook Platform to explore the full profile.See details»
Synermore Biologics
Synermore is a Taiwan based biotech company focused on the research and development of innovative and biosimilar monoclonal antibodies in the areas of oncology, infectious diseases, …See details»
Synermore - Crunchbase Company Profile & Funding
Synermore is a Taiwan based biotech company focused on the research and development of innovative and biosimilar monoclonal antibodies in the areas of oncology, infectious diseases, …See details»
Synermore Company Profile | Management and Employees List
Synermore Biologics (Suzhou) Co. Ltd. ("Synermore") is located in beautiful BioBay of Suzhou Industrial Park, and committed to developing and commercializing innovative and biosimilar …See details»
Synermore - Overview, News & Similar companies | ZoomInfo.com
Synermore Biologics (Suzhou) Co. Ltd. ("Synermore") is located in beautiful BioBay of Suzhou Industrial Park, and committed to developing and commercializing innovative and biosimilar …See details»
Synermore Biologics(Beijing) Co., Ltd. - Drug pipelines, Patents ...
Explore Synermore Biologics (Beijing) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Neoplasms, Technology Platform:Monoclonal …See details»
Hunan Nucien Pharmaceutical acquires Synermore - 2020-11-12 ...
Nov 12, 2020 · Synermore Synermore is a biotech company. Acquiring Organization: Hunan Nucien Pharmaceutical Hunan Nucien engages in the research and development, production, …See details»
Synermore - Products, Competitors, Financials, Employees, …
Synermore is a biotech company focused on the research and development of monoclonal antibodies in the fields of oncology, infectious diseases, and immune disorders. Use the CB …See details»
Interview: Eric Tsao - CEO and Founder, Synermore
May 24, 2017 · Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar …See details»
Synermore - Funding, Financials, Valuation & Investors - Crunchbase
Apr 26, 2024 · Synermore has raised 1 round. This was a Corporate Round round raised on Apr 26, 2024. Synermore is funded by Sinovac Biotech.See details»
SYN-004 by Synermore Biologics for Metastatic Colorectal Cancer ...
SYN-004 is under clinical development by Synermore Biologics and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase II drugs for Metastatic …See details»
Eric Tsao: Positions, Relations and Network - MarketScreener
Apr 18, 2024 · Chief Executive Officer at Synermore Biologics Co., Ltd., Discover Eric Tsao's known position history, network and 3 relationships. Find out about his known public assets.See details»
SYN-100 - Drug Targets, Indications, Patents - Synapse - Patsnap
5 days ago · Understand key drug designations in just a few clicks with Synapse. SYN-100: a Bacterial toxin inhibitors Drug, Initially developed by Synermore Biologics Co., Ltd.,See details»
Synermore - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Synermore is a biotech company. Start Free Trial . Chrome ExtensionSee details»
SYN023, a novel humanized monoclonal antibody cocktail, for …
Dec 20, 2017 · Here, we present the development of an antibody cocktail, SYN023, made of two novel monoclonal antibodies (MAb) CTB011 and CTB012 that could serve as safer and more …See details»
Eric Tsao, Ph.d. | Synermore Biologics | China - OMICS International
Dr. Eric Tsao has served as the Chief Executive Officer of Synermore Biologics since the founding of the company in 2013. He has over 25 years of direct experience with more than 20 products …See details»
Omalizumab biosimilar - Synermore Biologics - AdisInsight
If your organization or you do not have a subscription, try one of the following: Contacting your organization’s admin about adding this content to your AdisInsight subscription Buying a PDF …See details»
Corporate Round - Synermore - 2024-04-26 - Crunchbase
Apr 26, 2024 · Synermore raised an undisclosed amount on 2024-04-26 in Corporate Round. Sinovac Biotech Sinovac Biotech Ltd. is a China-based biopharmaceutical company that …See details»
SYN023, a novel humanized monoclonal antibody cocktail, for …
Dec 20, 2017 · Here, we present the development of an antibody cocktail, SYN023, made of two novel monoclonal antibodies (MAb) CTB011 and CTB012 that could serve as safer and more …See details»